News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Stem Cell Therapeutics To Cut Senior Jobs, Stock Drops
June 25, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
TORONTO (Reuters) - Stem Cell Therapeutics, a Canadian biotechnology company, said on Friday it would remove its senior executives to save money after the lead study of a stroke treatment failed to meet targets.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Phase II
Job creations
MORE ON THIS TOPIC
Alzheimer’s
Prothena’s Alzheimer’s Drug Comes With Familiar Side Effect in Phase I Test
August 28, 2025
·
2 min read
·
Annalee Armstrong
IN PARTNERSHIP WITH TRUVETA
Webinar: AI for Faster, More Precise Real-World Research: Extracting Clinical Notes Data at Scale
August 27, 2025
·
1 min read
·
BioSpace Insights
Labor market
Massachusetts R&D, Biomanufacturing Jobs Fell in ’24: Report
August 27, 2025
·
6 min read
·
Angela Gabriel
Regulatory
The US Is Losing Its Biopharma Edge, Writes Former FDA Commissioner
August 27, 2025
·
3 min read
·
Dan Samorodnitsky
